Disease_category,Disease,Protein,Protein_definition,NB_individual,NB_case,HR[95%CI],P_value
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",BCL2,Apoptosis regulator Bcl-2,14392,84,1.82 [1.51-2.20],2.766591160517415e-10
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",CCL3,C-C motif chemokine 3,16527,101,1.47 [1.25-1.73],2.5457886209412853e-06
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",CD22,B-cell receptor CD22,16731,101,2.60 [1.90-3.55],2.362740903973121e-09
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",CD27,CD27 antigen,16625,100,2.52 [1.75-3.65],8.857916510136453e-07
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",CD28,T-cell-specific surface glycoprotein CD28,16215,97,1.88 [1.39-2.55],5.176547630074422e-05
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",CD5,T-cell surface glycoprotein CD5,16688,100,2.87 [1.95-4.24],1.0230483888815925e-07
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",CD70,CD70 antigen,16527,101,2.54 [1.74-3.70],1.4874427745624215e-06
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",CD72,B-cell differentiation antigen CD72,14169,83,3.18 [2.07-4.88],1.1285998456644729e-07
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",CD74,HLA class II histocompatibility antigen gamma chain,16689,100,2.94 [1.89-4.57],1.8605718308867288e-06
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",CD79B,B-cell antigen receptor complex-associated protein beta chain,16731,101,2.93 [2.17-3.95],2.209215167647364e-12
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",CD80,T-lymphocyte activation antigen CD80,14451,83,5.17 [3.19-8.39],2.801076704285684e-11
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",CD83,CD83 antigen,16527,101,3.64 [2.35-5.63],7.053798627075771e-09
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,16527,101,1.48 [1.23-1.78],3.5539962881805606e-05
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",CR2,Complement receptor type 2,16655,100,2.05 [1.43-2.95],9.05775721307789e-05
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",CRTAM,Cytotoxic and regulatory T-cell molecule,16419,100,2.85 [2.08-3.93],1.0986653584994084e-10
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",CXCL13,C-X-C motif chemokine 13,16689,100,1.60 [1.42-1.80],1.0920518013766572e-14
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",CXCL9,C-X-C motif chemokine 9,16629,99,1.63 [1.32-2.01],4.377417100875587e-06
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",EPO,Erythropoietin,16527,101,1.45 [1.21-1.73],5.808099403760444e-05
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,14451,83,1.78 [1.35-2.33],3.383457735062264e-05
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",FCER2,Low affinity immunoglobulin epsilon Fc receptor,16578,100,2.00 [1.48-2.69],5.121555830767037e-06
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",FCRL1,Fc receptor-like protein 1,16547,97,2.10 [1.46-3.03],6.871655017112858e-05
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",FCRL2,Fc receptor-like protein 2,16646,100,2.55 [2.02-3.22],4.352112084205661e-15
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",FCRL3,Fc receptor-like protein 3,16270,96,2.50 [1.90-3.28],6.147301425538298e-11
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",HLA-E,"HLA class I histocompatibility antigen, alpha chain E",16527,101,3.05 [1.94-4.80],1.4844369653241806e-06
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",IL10,Interleukin-10,16270,96,1.43 [1.25-1.64],2.50562395617381e-07
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",IL12A_IL12B,Interleukin-12,16487,99,1.60 [1.31-1.96],3.7834360801910166e-06
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",IL12B,Interleukin-12 subunit beta,16731,101,1.95 [1.43-2.66],2.150719819426162e-05
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",IL2RA,Interleukin-2 receptor subunit alpha,16444,101,2.54 [1.74-3.71],1.3965409662901588e-06
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",LAG3,Lymphocyte activation gene 3 protein,16487,99,2.08 [1.45-3.00],8.110104428373477e-05
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,16270,96,2.09 [1.45-3.03],8.668763895536498e-05
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",LTA,Lymphotoxin-alpha,16527,101,1.96 [1.46-2.64],8.100529196333907e-06
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",LY9,T-lymphocyte surface antigen Ly-9,16350,99,4.54 [2.64-7.80],4.391037255615008e-08
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",NOS3,"Nitric oxide synthase, endothelial",16184,100,1.85 [1.57-2.17],1.211946347333719e-13
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",PDCD1,Programmed cell death protein 1,16685,98,2.71 [2.22-3.30],8.120371630536606e-23
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",SERPINA9,Serpin A9,16400,99,1.99 [1.63-2.42],1.4252795471990379e-11
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",SIGLEC10,Sialic acid-binding Ig-like lectin 10,16527,101,4.42 [2.85-6.87],3.615126713353651e-11
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",SIGLEC6,Sialic acid-binding Ig-like lectin 6,16716,100,3.37 [2.13-5.33],2.266822093654305e-07
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",SLAMF6,SLAM family member 6,16215,97,2.39 [1.58-3.61],3.779536325682684e-05
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",TIGIT,T-cell immunoreceptor with Ig and ITIM domains,14196,82,1.77 [1.37-2.28],1.0976267340280936e-05
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",TNF,Tumor necrosis factor,16238,97,1.80 [1.42-2.28],1.063263992461863e-06
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,16577,98,2.99 [2.20-4.05],1.673971286628149e-12
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,16270,96,4.27 [3.09-5.90],1.5671760101327912e-18
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,16578,100,1.70 [1.31-2.20],7.072548771831488e-05
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",TNFRSF4,Tumor necrosis factor receptor superfamily member 4,16706,101,3.69 [2.61-5.22],1.5357043696371892e-13
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",TNFRSF8,Tumor necrosis factor receptor superfamily member 8,16689,100,2.25 [1.67-3.03],9.81034158533407e-08
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",TNFRSF9,Tumor necrosis factor receptor superfamily member 9,16419,100,4.29 [3.34-5.53],1.0860687905051142e-29
Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",TNFSF8,Tumor necrosis factor ligand superfamily member 8,14466,85,2.63 [1.68-4.13],2.458403685747792e-05
